Cargando…
Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis
Atherosclerosis is a maladaptive chronic inflammatory disease, which remains the leading cause of death worldwide. The NLRP3 inflammasome constitutes a major driver of atherosclerosis, yet the mechanism of action is poorly understood. Mitochondrial dysfunction is essential for NLRP3 inflammasome act...
Autores principales: | Jin, Ying, Liu, Yao, Xu, Lei, Xu, Jie, Xiong, Yulian, Peng, Yazhi, Ding, Ke, Zheng, Shuang, Yang, Nan, Zhang, Zemei, Li, Lin, Tan, Liguo, Song, HongXian, Fu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156694/ https://www.ncbi.nlm.nih.gov/pubmed/35641492 http://dx.doi.org/10.1038/s41419-022-04966-8 |
Ejemplares similares
-
VX‐765 ameliorates renal injury and fibrosis in diabetes by regulating caspase‐1‐mediated pyroptosis and inflammation
por: Wen, Si, et al.
Publicado: (2021) -
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
por: Do Carmo, Helison, et al.
Publicado: (2018) -
VX-765 reduces neuroinflammation after spinal cord injury in mice
por: Chen, Jing, et al.
Publicado: (2021) -
Effect of VX-765 on the transcriptome profile of mice spinal cords with acute injury
por: Chen, Jing, et al.
Publicado: (2020) -
VX765, a Specific Caspase-1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction
por: Wu, Siyi, et al.
Publicado: (2021)